During previous stages of research, high biocidal activity
toward
microorganism archival strains has been used as the main indicator
in the development of new antiseptic formulations. Although this factor
remains one of the most important characteristics of biocide efficiency,
the scale of antimicrobial resistance spread causes serious concern.
Therefore, focus shifts toward the development of formulations with
a stable effect even in the case of prolonged contact with pathogens.
Here, we introduce an original isocyanuric acid alkylation method
with the use of available alkyl dichlorides, which opened access to
a wide panel of multi-QACs with alkyl chains of various lengths between
the nitrogen atoms of triazine and pyridine cycles. We used a complex
approach for the resulting series of 17 compounds, including their
antibiofilm properties, bacterial tolerance development, and antimicrobial
activity toward multiresistant pathogenic strains. As a result of
these efforts, available compounds have shown higher levels of antibacterial
activity against ESKAPE pathogens than widely used commercial QACs.
Hit compounds possessed high activity toward clinical bacterial strains
and have also demonstrated a long-term biocidal effect without significant
development of microorganism tolerance. The overall results indicated
a high level of antibacterial activity and the broad application prospects
of multi-QACs based on isocyanuric acid against multiresistant bacterial
strains.